Cascadian Therapeutics Inc (CASC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2002 | 09-2002 | 06-2002 | 03-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,850 | -4,740 | -5,030 | -4,740 | -24,980 |
| Depreciation Amortization | 850 | 140 | 160 | 150 | 830 |
| Other Working Capital | -3,990 | -150 | -1,530 | -1,660 | 8,820 |
| Other Operating Activity | -20 | -110 | 100 | 0 | -80 |
| Operating Cash Flow | $-23,010 | $-4,860 | $-6,300 | $-6,250 | $-15,410 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -160 | -90 | -70 | -9 | -420 |
| Net Acquisitions | 0 | 0 | 0 | 0 | -8,660 |
| Other Investing Activity | 21,300 | 3,340 | 1,830 | 7,889 | -10 |
| Investing Cash Flow | $21,140 | $3,250 | $1,760 | $7,880 | $-9,090 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -7,190 | -1,850 | -1,630 | -1,500 | 32,950 |
| Financing Cash Flow | $-7,190 | $-1,850 | $-1,630 | $-1,500 | $32,950 |
| Exchange Rate Effect | 20 | 100 | -90 | 0 | 80 |
| Beginning Cash Position | 14,420 | 8,470 | 14,770 | 14,280 | 6,180 |
| End Cash Position | 5,380 | 5,110 | 8,500 | 14,400 | 14,720 |
| Net Cash Flow | $-9,040 | $-3,360 | $-6,270 | $110 | $8,530 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,010 | -4,860 | -6,300 | -6,250 | -15,410 |
| Free Cash Flow | -23,010 | -4,860 | -6,300 | -6,250 | -15,410 |